{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T02:29:54Z","timestamp":1782354594103,"version":"3.54.5"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T00:00:00Z","timestamp":1687219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum W\u00fcrzburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmologie"],"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Diese Studie ist eine Analyse der Fluoreszeinangiographie (FAG) und der Indocyaningr\u00fcnangiographie (ICGA) im universit\u00e4tsmedizinischen Setting, deren prim\u00e4res Ziel die Analyse der unerw\u00fcnschten Arzneimittelwirkungen (UAW) und deren Schweregrad (mild, moderat, schwer) ist. Sekund\u00e4res Ziel der Studie ist es, die Indikationsstellung von FAG und ICGA vor und w\u00e4hrend der COVID-19-Pandemie zu untersuchen.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methodik<\/jats:title>\n                <jats:p>Eine retrospektive Analyse aller FAG und ICGA an der Universit\u00e4tsaugenklinik in W\u00fcrzburg im Zeitraum von Januar 2016 bis Ende Dezember 2021 wurde durchgef\u00fchrt. Dabei wurden UAW, Geschlecht, Alter, Untersuchungszeitpunkte und Indikation ausgewertet. Die Einteilung der UAW erfolgte in mild, moderat und schwer, angelehnt an die Definition von Kornblau et\u00a0al. [1].<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Insgesamt wurden 4900 Datens\u00e4tze von 4193\u00a0Patienten ausgewertet. Die FAG wurde etwas h\u00e4ufiger bei M\u00e4nnern (54,8\u202f%) als bei Frauen (45,2\u202f%) durchgef\u00fchrt, und das Durchschnittsalter betrug 63,2\u202f\u00b1\u200916,9\u00a0Jahre (Median: 65\u00a0Jahre). UAW traten nur bei 1,65\u202f% aller FAG auf, hiervon waren 1,27\u202f% milde und 0,39\u202f% moderate UAW. Es traten keine schweren UAW auf. Die h\u00e4ufigste UAW war mit 59,26\u202f% eine Nausea. Bei der ICGA traten keine UAW auf. Die j\u00e4hrliche Anzahl der FAG betrug durchschnittlich 816,7\u202f\u00b1\u200991,1 und war im gesamten Zeitraum bis auf eine signifikant reduzierte Anzahl im Jahr 2016 (im Vergleich zu 2018, 2019 und 2021) relativ konstant. Die h\u00e4ufigste Indikation zur FAG waren ven\u00f6se retinale Verschl\u00fcsse mit 22,93\u202f% (<jats:italic>N<\/jats:italic>\u202f=\u2009774), hierbei zeigte sich 2021 eine signifikante Zunahme im Vergleich zu den Jahren 2018 bis 2020. Eine ICGA wurde in 4,18\u202f% der F\u00e4lle durchgef\u00fchrt, wobei die h\u00e4ufigste Indikation eine Uveitis mit 31,82\u202f% (<jats:italic>N<\/jats:italic>\u202f=\u200963) war.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Diskussion<\/jats:title>\n                <jats:p>Im Vergleich zu anderen Studien kam es zu sehr wenigen UAW, und in keinem Fall kam es zu einer lebensbedrohlichen UAW. Ven\u00f6se retinale Verschl\u00fcsse waren sehr h\u00e4ufig die Indikation zur FAG, wahrscheinlich aufgrund der oft notwendigen Wiederholung der Untersuchung bei diesem Krankheitsbild. Kurzzeitig w\u00e4hrend des ersten Lockdowns (18.03. bis 08.05.2020) konnte eine Abnahme der Angiographien beobachtet werden, aber \u00fcber einen l\u00e4ngeren Zeitraum zeigten sich keine signifikanten Unterschiede im Vergleich zu der Zeit vor der Pandemie.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00347-023-01881-x","type":"journal-article","created":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T17:02:01Z","timestamp":1687280521000},"page":"1029-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Analyse von unerw\u00fcnschten Arzneimittelwirkungen (UAW) bei Fluoreszeinangiographie (FAG) und Indocyaningr\u00fcnangiographie (ICGA) und der Indikationsstellung vor und w\u00e4hrend der COVID-19-Pandemie an einer Universit\u00e4tsaugenklinik","Analysis of adverse drug reactions (ADR) in fluorescein angiography (FAG) and indocyanine green angiography (ICGA) and indications before and during the COVID-19 pandemic at a\u00a0university eye hospital"],"prefix":"10.1007","volume":"120","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9491-1846","authenticated-orcid":false,"given":"Nikolai","family":"Kleefeldt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"K\u00fchnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost","family":"Hillenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"William","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,20]]},"reference":[{"issue":"5","key":"1881_CR1","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.survophthal.2019.02.004","volume":"64","author":"IS Kornblau","year":"2019","unstructured":"Kornblau\u00a0IS, El-Annan\u00a0JF (2019) Adverse reactions to fluorescein angiography: a comprehensive review of the literature. Surv Ophthalmol 64(5):679\u2013693","journal-title":"Surv Ophthalmol"},{"key":"1881_CR2","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1161\/01.CIR.24.1.82","volume":"24","author":"HR Novotny","year":"1961","unstructured":"Novotny\u00a0HR, Alvis\u00a0DL (1961) A method of photographing fluorescence in circulating blood in the human retina. Circulation 24:82\u201386","journal-title":"Circulation"},{"issue":"8","key":"1881_CR3","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1007\/s00347-020-01117-2","volume":"117","author":"Deutsche Ophthalmologische Gesellschaft (DOG)","year":"2020","unstructured":"Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e.\u202fV. (RG), Berufsverband der Augen\u00e4rzte Deutschlands e.\u202fV. (BVA) (2020) Stellungnahme der DOG, der RG und des BVA zur Anti-VEGF-Therapie bei der neovaskul\u00e4ren altersabh\u00e4ngigen Makuladegeneration. Ophthalmologe 117(8):746\u2013754","journal-title":"Ophthalmologe"},{"issue":"3","key":"1881_CR4","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s00347-019-01015-2","volume":"117","author":"Deutsche Ophthalmologische Gesellschaft (DOG)","year":"2020","unstructured":"Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e.\u202fV. (RG), Berufsverband der Augen\u00e4rzte Deutschlands e.\u202fV. (BVA) (2020) Stellungnahme der DOG, der RG und des BVA zur Therapie des diabetischen Makula\u00f6dems. Ophthalmologe 117(3):218\u2013247","journal-title":"Ophthalmologe"},{"issue":"10","key":"1881_CR5","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1007\/s00347-018-0775-0","volume":"115","author":"Berufsverband der Augen\u00e4rzte Deutschlands e.V. (BVA)","year":"2018","unstructured":"Berufsverband der Augen\u00e4rzte Deutschlands e.V. (BVA), Deutsche Ophthalmologische Gesellschaft (DOG), Retinologische Gesellschaft e.V. (RG) (2018) Stellungnahme von BVA, DOG und RG zur intravitrealen Therapie des visusmindernden Makula\u00f6dems bei retinalem Venenverschluss. Ophthalmologe 115(10):842\u2013854","journal-title":"Ophthalmologe"},{"issue":"3","key":"1881_CR6","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/0002-9394(72)90079-7","volume":"73","author":"RW Flower","year":"1972","unstructured":"Flower\u00a0RW, Hochheimer\u00a0BF (1972) Clinical infrared absorption angiography of the choroid. Am J Ophthalmol 73(3):458\u2013459","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"1881_CR7","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S0161-6420(86)33697-2","volume":"93","author":"LA Yannuzzi","year":"1986","unstructured":"Yannuzzi\u00a0LA et\u00a0al (1986) Fluorescein angiography complication survey. Ophthalmology 93(5):611\u2013617","journal-title":"Ophthalmology"},{"issue":"7","key":"1881_CR8","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s00347-021-01374-9","volume":"118","author":"C Framme","year":"2021","unstructured":"Framme\u00a0C et al (2021) Influence of COVID-19 shutdown on the workload of a\u00a0university eye clinic. Ophthalmologe 118(7):659\u2013669","journal-title":"Ophthalmologe"},{"issue":"9","key":"1881_CR9","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s00347-020-01220-4","volume":"117","author":"LO Hattenbach","year":"2020","unstructured":"Hattenbach\u00a0LO et al (2020) Auswirkungen der SARS-CoV-2-Pandemie auf die ophthalmologische Versorgung in Deutschland. Ophthalmologe 117(9):892\u2013904","journal-title":"Ophthalmologe"},{"key":"1881_CR10","unstructured":"Alcon Fachinformation Fluorescein ALCON\u00ae 10, Version 05\/2017"},{"key":"1881_CR11","unstructured":"Green D Fachinformation Verdye, Version 01\/2016"},{"issue":"11","key":"1881_CR12","first-page":"1084","volume":"15","author":"RW Butner","year":"1983","unstructured":"Butner\u00a0RW, McPherson\u00a0AR (1983) Adverse reactions in intravenous fluorescein angiography. Ann Ophthalmol 15(11):1084\u20131086","journal-title":"Ann Ophthalmol"},{"issue":"6","key":"1881_CR13","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1111\/j.1600-0420.2006.00728.x","volume":"84","author":"F Musa","year":"2006","unstructured":"Musa\u00a0F et\u00a0al (2006) Adverse effects of fluorescein angiography in hypertensive and elderly patients. Acta Ophthalmol Scand 84(6):740\u2013742","journal-title":"Acta Ophthalmol Scand"},{"issue":"1","key":"1881_CR14","first-page":"32","volume":"14","author":"RI Pacurariu","year":"1982","unstructured":"Pacurariu\u00a0RI (1982) Low incidence of side effects following intravenous fluorescein angiography. Ann Ophthalmol 14(1):32\u201336","journal-title":"Ann Ophthalmol"},{"key":"1881_CR15","unstructured":"Akorn Highlights of prescribing information, Version 08\/2019"},{"issue":"12","key":"1881_CR16","first-page":"553","volume":"64","author":"V Mattioli","year":"1998","unstructured":"Mattioli\u00a0V et al (1998) Oral granisetron as prophylaxis for nausea and vomiting during fluorescein angiography. A multicentre, double-blind, randomised, parallel group, placebo-controlled study. Minerva Anestesiol 64(12):553\u2013561","journal-title":"Minerva Anestesiol"},{"issue":"5","key":"1881_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1001\/archopht.1987.01060050076041","volume":"105","author":"RE Brown Jr","year":"1987","unstructured":"Brown\u00a0RE Jr, Sabates\u00a0R, Drew\u00a0SJ (1987) Metoclopramide as prophylaxis for nausea and vomiting induced by fluorescein. Arch Ophthalmol 105(5):658\u2013659","journal-title":"Arch Ophthalmol"},{"key":"1881_CR18","first-page":"190","volume":"78","author":"PP Ellis","year":"1980","unstructured":"Ellis\u00a0PP, Schoenberger\u00a0M, Rendi\u00a0MA (1980) Antihistamines as prophylaxis against side reactions to intravenous fluorescein. Trans Am Ophthalmol Soc 78:190\u2013205","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"1","key":"1881_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0161-6420(02)01563-4","volume":"110","author":"PE Stanga","year":"2003","unstructured":"Stanga\u00a0PE, Lim\u00a0JI, Hamilton\u00a0P (2003) Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 110(1):15\u201321 (quiz 22-3)","journal-title":"Ophthalmology"},{"issue":"5","key":"1881_CR20","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10792-008-9263-x","volume":"30","author":"I Tugal-Tutkun","year":"2010","unstructured":"Tugal-Tutkun\u00a0I et al (2010) Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol 30(5):539\u2013552","journal-title":"Int Ophthalmol"},{"issue":"1","key":"1881_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41433-020-1072-0","volume":"35","author":"CP Herbort Jr.","year":"2021","unstructured":"Herbort\u00a0CP Jr. et\u00a0al (2021) Advances and potential new developments in imaging techniques for posterior uveitis part 2: invasive imaging methods. Eye (Lond) 35(1):52\u201373","journal-title":"Eye (Lond)"},{"issue":"3","key":"1881_CR22","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/ICU.0000000000000562","volume":"30","author":"AS Thomas","year":"2019","unstructured":"Thomas\u00a0AS (2019) Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics. Curr Opin Ophthalmol 30(3):138\u2013150","journal-title":"Curr Opin Ophthalmol"},{"issue":"3","key":"1881_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/09273948.2019.1605264","volume":"27","author":"ET Cunningham Jr.","year":"2019","unstructured":"Cunningham\u00a0ET Jr. et al (2019) Ultra-wide-field imaging in uveitis. Ocul Immunol Inflamm 27(3):345\u2013348","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"1881_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/08820530802520095","volume":"24","author":"A Kaines","year":"2009","unstructured":"Kaines\u00a0A et\u00a0al (2009) The use of ultra wide field fluorescein angiography in evaluation and management of uveitis. Semin Ophthalmol 24(1):19\u201324","journal-title":"Semin Ophthalmol"},{"issue":"18","key":"1881_CR25","doi-asserted-by":"publisher","first-page":"5421","DOI":"10.3390\/jcm11185421","volume":"11","author":"Z Jiang","year":"2022","unstructured":"Jiang\u00a0Z et al (2022) Oral fluorescein angiography with ultra-wide-field scanning laser ophthalmoscopy in pediatric patients precis: oral fluorescein angiography in children. J\u00a0Clin Med 11(18):5421. https:\/\/doi.org\/10.3390\/jcm11185421","journal-title":"J Clin Med"},{"issue":"6","key":"1881_CR26","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1097\/IAE.0000000000003011","volume":"41","author":"S Yamao","year":"2021","unstructured":"Yamao\u00a0S et al (2021) Utility of oral fluorescein angiography with ultra-widefield imaging system for evaluation of various retinal disorders. Retina 41(6):1338\u20131345","journal-title":"Retina"},{"issue":"5","key":"1881_CR27","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jfo.2019.09.013","volume":"43","author":"JF Le Rouic","year":"2020","unstructured":"Le Rouic\u00a0JF et\u00a0al (2020) Indications for fluorescein angiography and optical coherence tomography angiography (OCTA) in medical retina: changes from 2015 and 2018. J\u00a0Fr Ophtalmol 43(5):397\u2013403","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"1881_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.4103\/0974-9233.173132","volume":"23","author":"A Patel","year":"2016","unstructured":"Patel\u00a0A, Nguyen\u00a0C, Lu\u00a0S (2016) Central retinal vein occlusion: a review of current evidence-based treatment options. Middle East Afr J Ophthalmol 23(1):44\u201348","journal-title":"Middle East Afr J Ophthalmol"},{"key":"1881_CR29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12886-016-0282-5","volume":"16","author":"SE Bradshaw","year":"2016","unstructured":"Bradshaw\u00a0SE et\u00a0al (2016) Systematic literature review of treatments for management of complications of ischemic central retinal vein occlusion. BMC Ophthalmol 16:104","journal-title":"BMC Ophthalmol"},{"issue":"10","key":"1881_CR30","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1038\/s41433-020-0861-9","volume":"34","author":"JL Ang","year":"2020","unstructured":"Ang\u00a0JL et al (2020) A systematic review of real-world evidence of the management of macular oedema secondary to branch retinal vein occlusion. Eye (Lond) 34(10):1770\u20131796","journal-title":"Eye (Lond)"},{"issue":"8","key":"1881_CR31","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.jfo.2011.06.001","volume":"34","author":"T Desmettre","year":"2011","unstructured":"Desmettre\u00a0T et\u00a0al (2011) Current uses and indications for indocyanine green angiography. J\u00a0Fr Ophtalmol 34(8):568\u2013582","journal-title":"J Fr Ophtalmol"},{"issue":"1","key":"1881_CR32","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00347-015-0192-6","volume":"113","author":"PP Fang","year":"2016","unstructured":"Fang\u00a0PP et\u00a0al (2016) Clinical applications of OCT angiography. Ophthalmologe 113(1):14\u201322","journal-title":"Ophthalmologe"},{"issue":"5","key":"1881_CR33","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1055\/s-0042-105325","volume":"233","author":"GE Lang","year":"2016","unstructured":"Lang\u00a0GE, Enders\u00a0C, Werner\u00a0JU (2016) New possibilities in retinal diagnostics using OCT angiography. Klin Monbl Augenheilkd 233(5):613\u2013621","journal-title":"Klin Monbl Augenheilkd"},{"issue":"6","key":"1881_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1007\/s00347-021-01375-8","volume":"118","author":"M Alnawaiseh","year":"2021","unstructured":"Alnawaiseh\u00a0M, Leclaire\u00a0MD, Eter\u00a0N (2021) Optical coherence tomography angiography (OCT-A) : overview of the technique and the possible clinical and scientific applications. Ophthalmologe 118(6):617\u2013629","journal-title":"Ophthalmologe"},{"issue":"11","key":"1881_CR35","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.4103\/ijo.IJO_2575_20","volume":"68","author":"JA Walinjkar","year":"2020","unstructured":"Walinjkar\u00a0JA et al (2020) Central retinal vein occlusion with COVID-19 infection as the presumptive etiology. Indian J Ophthalmol 68(11):2572\u20132574","journal-title":"Indian J Ophthalmol"},{"issue":"1","key":"1881_CR36","doi-asserted-by":"publisher","first-page":"308","DOI":"10.4103\/ijo.IJO_1757_21","volume":"70","author":"NJ Sonawane","year":"2022","unstructured":"Sonawane\u00a0NJ et al (2022) Central retinal vein occlusion post-COVID-19 vaccination. Indian J Ophthalmol 70(1):308\u2013309","journal-title":"Indian J Ophthalmol"},{"key":"1881_CR37","unstructured":"Anzahl Infektionen und Todesf\u00e4lle in Zusammenhang mit dem Coronavirus (COVID-19) in Deutschland seit Februar 2020. https:\/\/de.statista.com\/statistik\/daten\/studie\/1102667\/umfrage\/erkrankungs-und-todesfaelle-aufgrund-des-coronavirus-in-deutschland\/. Zugegriffen: 1. Apr. 2023"}],"container-title":["Die Ophthalmologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01881-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00347-023-01881-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00347-023-01881-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T15:04:21Z","timestamp":1697727861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00347-023-01881-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,20]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1881"],"URL":"https:\/\/doi.org\/10.1007\/s00347-023-01881-x","relation":{},"ISSN":["2731-720X","2731-7218"],"issn-type":[{"value":"2731-720X","type":"print"},{"value":"2731-7218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,20]]},"assertion":[{"value":"30 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"N.\u00a0Kleefeldt, A.\u00a0Schneider, S.\u00a0K\u00fchnel, J.\u00a0Hillenkamp und A.\u00a0William geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}